364 related articles for article (PubMed ID: 22851526)
21. Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease.
Mehrotra S; Paramasivam G; Mishra S
Curr Cardiol Rep; 2017 Feb; 19(2):10. PubMed ID: 28185166
[TBL] [Abstract][Full Text] [Related]
22. Differential clinical responses to everolimus-eluting and Paclitaxel-eluting coronary stents in patients with and without diabetes mellitus.
Stone GW; Kedhi E; Kereiakes DJ; Parise H; Fahy M; Serruys PW; Smits PC
Circulation; 2011 Aug; 124(8):893-900. PubMed ID: 21824922
[TBL] [Abstract][Full Text] [Related]
23. Meta-analysis of randomized trials of drug-eluting stents versus bare metal stents in patients with diabetes mellitus.
Boyden TF; Nallamothu BK; Moscucci M; Chan PS; Grossman PM; Tsai TT; Chetcuti SJ; Bates ER; Gurm HS
Am J Cardiol; 2007 May; 99(10):1399-402. PubMed ID: 17493468
[TBL] [Abstract][Full Text] [Related]
24. Comparative safety and efficacy of a sirolimus-eluting versus paclitaxel-eluting stent: a meta-analysis.
Gurm HS; Boyden T; Welch KB
Am Heart J; 2008 Apr; 155(4):630-9. PubMed ID: 18371469
[TBL] [Abstract][Full Text] [Related]
25. Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial.
Zeller T; Baumgartner I; Scheinert D; Brodmann M; Bosiers M; Micari A; Peeters P; Vermassen F; Landini M; Snead DB; Kent KC; Rocha-Singh KJ;
J Am Coll Cardiol; 2014 Oct; 64(15):1568-76. PubMed ID: 25301459
[TBL] [Abstract][Full Text] [Related]
26. Association of Survival With Femoropopliteal Artery Revascularization With Drug-Coated Devices.
Secemsky EA; Kundi H; Weinberg I; Jaff MR; Krawisz A; Parikh SA; Beckman JA; Mustapha J; Rosenfield K; Yeh RW
JAMA Cardiol; 2019 Apr; 4(4):332-340. PubMed ID: 30747949
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials.
Dibra A; Kastrati A; Alfonso F; Seyfarth M; Pérez-Vizcayno MJ; Mehilli J; Schömig A
J Am Coll Cardiol; 2007 Feb; 49(5):616-23. PubMed ID: 17276188
[TBL] [Abstract][Full Text] [Related]
28. Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease.
Rosenfield K; Jaff MR; White CJ; Rocha-Singh K; Mena-Hurtado C; Metzger DC; Brodmann M; Pilger E; Zeller T; Krishnan P; Gammon R; Müller-Hülsbeck S; Nehler MR; Benenati JF; Scheinert D;
N Engl J Med; 2015 Jul; 373(2):145-53. PubMed ID: 26106946
[TBL] [Abstract][Full Text] [Related]
29. Coronary stenting versus balloon angioplasty for acute myocardial infarction: a meta-regression analysis of randomized trials.
De Luca G; Suryapranata H; Stone GW; Antoniucci D; Biondi-Zoccai G; Kastrati A; Chiariello M; Marino P
Int J Cardiol; 2008 May; 126(1):37-44. PubMed ID: 17544528
[TBL] [Abstract][Full Text] [Related]
30. Drug-Coated Balloon Versus Plain Balloon Angioplasty for the Treatment of Femoropopliteal Artery Disease: An Updated Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Giacoppo D; Cassese S; Harada Y; Colleran R; Michel J; Fusaro M; Kastrati A; Byrne RA
JACC Cardiovasc Interv; 2016 Aug; 9(16):1731-42. PubMed ID: 27539695
[TBL] [Abstract][Full Text] [Related]
31. Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials.
Kasapis C; Henke PK; Chetcuti SJ; Koenig GC; Rectenwald JE; Krishnamurthy VN; Grossman PM; Gurm HS
Eur Heart J; 2009 Jan; 30(1):44-55. PubMed ID: 19028778
[TBL] [Abstract][Full Text] [Related]
32. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease.
Schömig A; Dibra A; Windecker S; Mehilli J; Suárez de Lezo J; Kaiser C; Park SJ; Goy JJ; Lee JH; Di Lorenzo E; Wu J; Jüni P; Pfisterer ME; Meier B; Kastrati A
J Am Coll Cardiol; 2007 Oct; 50(14):1373-80. PubMed ID: 17903638
[TBL] [Abstract][Full Text] [Related]
33. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg.
Tepe G; Zeller T; Albrecht T; Heller S; Schwarzwälder U; Beregi JP; Claussen CD; Oldenburg A; Scheller B; Speck U
N Engl J Med; 2008 Feb; 358(7):689-99. PubMed ID: 18272892
[TBL] [Abstract][Full Text] [Related]
34. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial.
Tepe G; Laird J; Schneider P; Brodmann M; Krishnan P; Micari A; Metzger C; Scheinert D; Zeller T; Cohen DJ; Snead DB; Alexander B; Landini M; Jaff MR;
Circulation; 2015 Feb; 131(5):495-502. PubMed ID: 25472980
[TBL] [Abstract][Full Text] [Related]
35. Drug-Coated Balloon Versus Standard Balloon for Superficial Femoral Artery In-Stent Restenosis: The Randomized Femoral Artery In-Stent Restenosis (FAIR) Trial.
Krankenberg H; Tübler T; Ingwersen M; Schlüter M; Scheinert D; Blessing E; Sixt S; Kieback A; Beschorner U; Zeller T
Circulation; 2015 Dec; 132(23):2230-6. PubMed ID: 26446728
[TBL] [Abstract][Full Text] [Related]
36. Drug-coated balloons and their place in treating peripheral arterial disease.
Schnorr B; Albrecht T
Expert Rev Med Devices; 2013 Jan; 10(1):105-14. PubMed ID: 23278227
[TBL] [Abstract][Full Text] [Related]
37. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
38. Two-Year Mortality After Angioplasty of the Femoro-Popliteal Artery with Uncoated Balloons and Paclitaxel-Coated Balloons-A Pooled Analysis of Four Randomized Controlled Multicenter Trials.
Albrecht T; Schnorr B; Kutschera M; Waliszewski MW
Cardiovasc Intervent Radiol; 2019 Jul; 42(7):949-955. PubMed ID: 30843092
[TBL] [Abstract][Full Text] [Related]
39. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
[TBL] [Abstract][Full Text] [Related]
40. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
